Senior Director
Foghorn Therapeutics
Joined Foghorn Therapeutics in 2018, previously doing computational biology / bioinformatics at Broad Institute / Cancer Program / Connectivity Map / PRISM groups, prior to that at the Broad in the Center for Development of Therapeutics as a software engineer / data science group leader.
Ph.D. in Physical Chemistry from MIT, NRC postdoctoral fellowship at National Institute of Standards and Technology.
